| 1 |
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
Quinn T. Ostrom, Haley R Gittleman, P Farah et al. · Neuro-Oncology
Open access |
17 Oct 2013 |
12,109 |
| 2 |
Cancer treatment and survivorship statistics, 2016
Kimberly D. Miller, Rebecca L. Siegel, Chun Chieh Lin et al. · CA A Cancer Journal for Clinicians
Open access |
2 Jun 2016 |
6,175 |
| 3 |
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
Shannon L. Maude et al. · New England Journal of Medicine
Open access |
31 Jan 2018 |
5,818 |
| 4 |
CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
Bertrand Coiffier, Éric Lepage, Josette Brière et al. · New England Journal of Medicine
Open access |
24 Jan 2002 |
5,630 |
| 5 |
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Shannon L. Maude, Noelle V. Frey, Pamela A. Shaw et al. · New England Journal of Medicine
Open access |
15 Oct 2014 |
5,489 |
| 6 |
Cancer Statistics, 2006
Ahmedin Jemal, Rebecca L. Siegel, Elizabeth M. Ward et al. · CA A Cancer Journal for Clinicians
Open access |
Mar 2006 |
5,346 |
| 7 |
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal et al. · New England Journal of Medicine
Open access |
26 Nov 2014 |
4,900 |
| 8 |
Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study
Mark Stephen Pearce, Jane A Salotti, Mark P. Little et al. · The Lancet
Open access |
6 Jun 2012 |
3,723 |
| 9 |
Chronic Health Conditions in Adult Survivors of Childhood Cancer
Kevin Charles Oeffinger, Ann C. Mertens, Charles A. Sklar et al. · New England Journal of Medicine
|
11 Oct 2006 |
3,647 |
| 10 |
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
Stephan A. Grupp, Michael D. Kalos, David Maxwell Barrett et al. · New England Journal of Medicine
Open access |
25 Mar 2013 |
3,532 |
| 11 |
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
Hartmut Döhner, Elihu H. Estey, Sergio Amadori et al. · Blood
Open access |
30 Oct 2009 |
3,422 |
| 12 |
Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification
Mercedes E. Gorre, Mansoor Mohammed, Katharine B. Ellwood et al. · Science
|
3 Aug 2001 |
3,120 |
| 13 |
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Andrew James Souers et al. · Nature Medicine
|
6 Jan 2013 |
3,089 |
| 14 |
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
Mohamed Lotfy Sorror, Michael B. Maris, Rainer F Storb et al. · Blood
Open access |
30 Jun 2005 |
2,978 |
| 15 |
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
Daniel W Lee, James N. Kochenderfer, Maryalice Stetler‐Stevenson et al. · The Lancet
Open access |
13 Oct 2014 |
2,968 |
| 16 |
Graft-versus-leukemia reactions after bone marrow transplantation
MM Horowitz, Gale Rp, Sondel Pm et al. · Blood
Open access |
Feb 1990 |
2,780 |
| 17 |
Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia
Andrew P. Weng, Adolfo A. Ferrando, Woojoong Lee et al. · Science
|
7 Oct 2004 |
2,749 |
| 18 |
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
Jae H. Park, Isabelle Rivière, Mithat Gönen et al. · New England Journal of Medicine
Open access |
31 Jan 2018 |
2,736 |
| 19 |
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
Brian J. Druker, Charles L. Sawyers, Hagop M. Kantarjian et al. · New England Journal of Medicine
Open access |
5 Apr 2001 |
2,735 |
| 20 |
The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial
David J. Grimwade, Helen M. Walker, Fiona Oliver et al. · Blood
Open access |
Oct 1998 |
2,644 |
| 21 |
Hematopoietic Stem-Cell Transplantation
Edward Alan Copelan · New England Journal of Medicine
|
26 Apr 2006 |
2,517 |
| 22 |
Childhood and adolescent cancer statistics, 2014
Elizabeth Ward, Carol E. Desantis, Anthony S. Robbins et al. · CA A Cancer Journal for Clinicians
Open access |
31 Jan 2014 |
2,451 |
| 23 |
Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
Meng‐Er Huang, YC Ye, S R Chen et al. · Blood
Open access |
Aug 1988 |
2,431 |
| 24 |
Acute Lymphoblastic Leukemia in Children
Stephen P. Hunger, Charles Grenfell Mullighan · New England Journal of Medicine
|
14 Oct 2015 |
2,272 |
| 25 |
Global cancer transitions according to the Human Development Index (2008–2030): a population-based study
Freddie Bray, Ahmedin Jemal, Nathan Grey et al. · The Lancet Oncology
|
31 May 2012 |
2,241 |
| 26 |
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012
Quinn T. Ostrom, Haley R Gittleman, Jordonna Fulop et al. · Neuro-Oncology
Open access |
Oct 2015 |
2,181 |
| 27 |
Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia
Hagop Kantarjian et al. · New England Journal of Medicine
Open access |
Mar 2017 |
2,162 |
| 28 |
Hematopoietic Reconstitution in a Patient with Fanconi's Anemia by Means of Umbilical-Cord Blood from an HLA-Identical Sibling
ELIANE GLUCKMAN, HE Broxmeyer, Arleen D. Auerbach et al. · New England Journal of Medicine
|
26 Oct 1989 |
2,113 |
| 29 |
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group
Michael G. Pfreundschuh et al. · The Lancet Oncology
|
7 Apr 2006 |
2,098 |
| 30 |
CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia
Renier J. Brentjens et al. · Science Translational Medicine
Open access |
20 Mar 2013 |
2,098 |
| 31 |
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.
Ann‐Lii Cheng et al. · PubMed
|
10 Dec 2001 |
2,081 |
| 32 |
Treatment of Acute Lymphoblastic Leukemia
Ching‐Hon Pui, William Edward Evans · New England Journal of Medicine
|
11 Jan 2006 |
1,998 |
| 33 |
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
David J. Grimwade, Robert K. Hills, Anthony V. Moorman et al. · Blood
Open access |
12 Apr 2010 |
1,972 |
| 34 |
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
Andrew Warwick Roberts, Matthew Steven Davids, John M. Pagel et al. · New England Journal of Medicine
Open access |
6 Dec 2015 |
1,929 |
| 35 |
Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling
Eng-Juh Yeoh et al. · Cancer Cell
Open access |
Mar 2002 |
1,928 |
| 36 |
Physiological concentrations of purines and pyrimidines
Thomas W. Traut · Molecular and Cellular Biochemistry
|
1994 |
1,917 |
| 37 |
Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid
Katherine K. Matthay, Judith Grob Villablanca, Robert C. Seeger et al. · New England Journal of Medicine
Open access |
14 Oct 1999 |
1,915 |
| 38 |
A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1
Jochen Hampe et al. · Nature Genetics
|
31 Dec 2006 |
1,911 |
| 39 |
Carboplatin dosage: prospective evaluation of a simple formula based on renal function.
A. Hilary Calvert, David R. Newell, Lindsey A. Gumbrell et al. · Journal of Clinical Oncology
|
Nov 1989 |
1,893 |
| 40 |
AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis
Tsukasa Okuda, Jan M. van Deursen, Scott W. Hiebert et al. · Cell
Open access |
1996 |
1,882 |
| 41 |
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia
Charles Grenfell Mullighan, Salil Goorha, Ina Radtke et al. · Nature
|
7 Mar 2007 |
1,832 |
| 42 |
International incidence of childhood cancer, 2001–10: a population-based registry study
Eva Steliarova‐Foucher et al. · The Lancet Oncology
Open access231 authors |
11 Apr 2017 |
1,807 |
| 43 |
Mutation in TET2 in Myeloid Cancers
François Delhommeau et al. · New England Journal of Medicine
Open access |
27 May 2009 |
1,770 |
| 44 |
Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis
Christian Thiede, Christine Steudel, Brigitte Mohr et al. · Blood
Open access |
15 Jun 2002 |
1,749 |
| 45 |
MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia
Scott A. Armstrong, Jane E. Staunton, Lewis B. Silverman et al. · Nature Genetics
|
3 Dec 2001 |
1,732 |
| 46 |
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
Jinghui Zhang et al. · Nature
Open access |
2012 |
1,643 |
| 47 |
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
Francesco Lo‐Coco et al. · New England Journal of Medicine
Open access |
10 Jul 2013 |
1,642 |
| 48 |
Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia
Richard F. Schlenk, Konstanze Döhner, Jürgen Krauter et al. · New England Journal of Medicine
|
30 Apr 2008 |
1,641 |
| 49 |
Mechanisms of Cisplatin Nephrotoxicity
Ronald P. Miller, Raghu Kempegowda Tadagavadi, Ganesan Ramesh et al. · Toxins
Open access |
26 Oct 2010 |
1,631 |
| 50 |
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)
John C. Byrd · Blood
|
Aug 2002 |
1,623 |